Turning Point Therapeutics, Inc. announced that Effective as of March 31, 2021, Brian Baker, the company’s Senior Vice President, Finance and Administration and principal accounting officer, will act as the company’s interim principal financial officer, for the purposes of the Securities Exchange Act of 1934, as amended. Brian Baker, M.S., C.P.A. has served as company's Senior Vice President of Finance and Administration since July 1, 2020 and prior to that as Vice President of Finance and Administration since 2017.